NFKB1 and autoimmune disease: While the increase in inflammation induced by loss of DDX39B likely contributes to autoimmune disease [23, 24], given the importance of NF-κB-mediated inflammation to therapy resistance [50], the increased inflammation seen with decreased DDX39B likely also underlies the resistance to chemotherapy.